How Can Brain Organoids Help Us Make Inferences about Brain Evolution?

Core Concepts

What organoids are and how they are made

Organoids begin with pluripotent stem cells — induced pluripotent stem cells (iPSCs) from skin or blood samples, or embryonic stem cells. Guided by signaling molecules that mimic early brain development (e.g., dual SMAD inhibition to promote neural ectoderm), the cells form neuroectoderm, then neural progenitors, and are grown in 3D — often embedded in an extracellular-matrix gel and kept in a spinning bioreactor so nutrients reach the interior. Over weeks to months they self-organize into layered tissue containing neural progenitors, neurons, and (in longer cultures) some glia, with structures resembling early cortical organization — ventricular-zone-like layers, progenitor zones, and neurons expressing region-appropriate markers. Different protocols bias organoids toward forebrain, midbrain, or other regional identities.

What organoids model: development, not the adult brain

Organoids best model early neurodevelopment: progenitor proliferation, the birth and migration of neurons, and the establishment of basic layers — the processes that most distinguish the human brain from other species' brains. They have been used to model microcephaly (organoids from patients show reduced progenitor proliferation), to show that Zika virus infects and kills neural progenitors (explaining the microcephaly outbreak association), and to test candidate drugs. They are also increasingly used to study neuropsychiatric genetics, since patient-derived iPSCs carry the patient's own mutations. What they do not model: mature circuit function, complex cognition, sensory experience, or behavior — there is no "mind" in a dish.

Organoids as an evolutionary laboratory

The classic evolutionary experiment is a species comparison: grow organoids from human and chimpanzee iPSCs under identical conditions and ask what differs. Studies report human organoids are larger, contain more neural progenitors (especially outer radial glia, a cell type expanded in humans), and show a slower, more prolonged developmental tempo, with differences in gene-expression programs related to proliferation and synapse formation. Some groups have gone further, using genome editing to introduce or revert human-specific gene variants in chimpanzee or human cells and watching the developmental consequences — an "evolution in a dish" approach. These experiments test hypotheses about human brain evolution that could never be tested in living great apes, which cannot be experimentally manipulated.

Strengths of the organoid approach

Organoids offer three advantages over the alternatives. Human tissue: they are the only way to study living human neural development with genetic control. Comparability: human and chimpanzee organoids can be grown in the same batch, under identical conditions, removing environmental confounds that plague field comparisons. Ethics and scale: they replace some animal experiments, can be produced from many individuals, and allow longitudinal observation of processes (like neuronal maturation) that take years in a real human brain.

Limitations: why organoids are not mini-brains

The limitations are substantial and shape what conclusions are legitimate. Organoids are small (typically millimeter-scale), lack vasculature, so interiors become hypoxic and develop necrotic cores — which itself limits growth. They lack sensory input and motor output, so they never develop the activity-dependent refinement of real brains. They contain immature neurons that rarely reach fully adult properties, and different batches can be highly variable. Most importantly, organoids lack the long-range connectivity and global architecture of a brain, so they cannot tell you about cognition, language, or consciousness. An organoid is a model of early cortical development, not a model of a brain.

Ethical considerations

Organoids raise genuine ethical questions that are actively debated. Because they lack the architecture, connectivity, and input/output needed for sentience, the consensus view is that current organoids are not conscious — but the closer they get to brain-like activity, the more scrutiny is warranted. Additional questions concern chimeras (transplanting human organoids into animal brains for study), consent and ownership of donor-derived tissue, and the use of organoids to study human-specific traits in ways that could be misused. Guidelines emphasize transparency, oversight, and limiting organoid maturation when concerns arise. For the student, the key point: the science is young, moving fast, and ethically governed by evolving standards.

What organoids can and cannot tell us about evolution

Properly used, organoids can address: Did human-specific genes (e.g., ARHGAP11B, NOTCH2NL — genes implicated in progenitor expansion) increase neuron production? Is the human developmental slowdown a cell-intrinsic property? How do modern-human variants differ from Neanderthal variants (studied by editing ancient alleles into stem cells)? What they cannot address: how the organoid's cell types function in a whole brain, what cognitive differences resulted, or the selective pressures that drove the changes. Organoid evolution studies generate mechanistic hypotheses about development; testing them in whole organisms requires complementary approaches.

Common Confusions